February 2026: Healthcare M&A Snapshot

View our summary of the key M&A, private equity and venture capital deals across the UK healthcare sector in February 2026 below.

Notable Sector Deals: February 2026

An interesting acquisition for Medica, bringing innovative technology-enabled diagnostics provider, Axon Diagnostics, into the group
The enlarged organisation will become the UK’s largest clinical reporting network, supporting more than 2.5 million patients annually across the majority of NHS Trusts
As part of the transaction, Axon’s sister company MITIS Health will also join Medica and bring its Clinical Desktop technology to the group
The deal is expected to increase capacity, accelerate turnaround times, enhance the experience for healthcare partners and patients, and create a stronger platform for innovation, including the potential use of AI

A significant transaction in the occupational health market, with Optima Health agreeing to acquire PAM Healthcare for total consideration c.£100m
The deal marks a successful exit for LDC, which has backed PAM since 2021 through a period of growth in the UK and Republic of Ireland
Optima claims the combined group will be the clear market leader with a 15% proforma market share and accelerates progress towards the group’s target of 25% market share
With the UK and Irish market valued at c.£1.6bn and remaining fragmented, consolidation continues to be undertaken by private equity-backed operators such as Latus Group, Health Partners and Medigold

* Deal remains subject to clearance from the Irish Foreign Direct Investment regime

Access Infinity has secured a strategic investment from CBPE to accelerate its next phase of growth, platform innovation and international expansion
Founded in 2014, Access Infinity combines innovative software solutions with expert consulting to help life sciences clients navigate global market access challenges, optimise pricing strategies and deliver value to patients
The partnership will enable further enhancement of Access Infinity’s technology platform and support continued investment in talent, innovation and client service
The deal highlights continued private equity interest in the market access sector, with further activity anticipated in 2026

Another notable deal in the complex care sector, with Sovereign Capital Partners acquiring Apollo Home Healthcare
Apollo is a specialist provider of complex home healthcare services, delivering long-term, nurse-led care packages to clients with high acuity needs
The business supports adults and children, working in partnership with NHS commissioners and case managers to deliver tailored care in patients’ homes
Sovereign’s investment is intended to support Apollo’s next phase of growth, including further geographic expansion and continued investment in clinical quality and infrastructure

Sub-sector	Target	Acquirer / Investor	Exiting PE
Medical Equipment	Rayner	GBL	N/A
Clinical Services	Axon Diagnostics	Medica (IK Partners)	N/A
Pharma Services	Access Infinity	CBPE	N/A
Clinical Services	Hallmarq Veterinary Imaging	OR Technology (Nord Holding)	August Equity
Occupational Health	PAM Healthcare	Optima Group	LDC
Occupational Health	Euro Environmental	Latus Group (NorthEdge)	N/A
Specialist Care	Apollo Home Healthcare	Sovereign Capital	N/A
Medical Equipment	Derbyshire Mobility	Eden Mobility (Foresight)	N/A

Target	Description	Lead Investor	Investment
Orthofuse	Surgeon‑adjustable 3D‑printed implants	ACF Investors	£2.2m
Brainomix	AI imaging provider	Parkwalk Advisors	£4.8m
Neupulse	Device which eases the symptoms of Tourette's syndrome	Eos Advisory Mercia	£3m
ClotProtect	Technology to reduce the risks associated with blood clots	Lifted Ventures	£1.2m
Centauri Therapeutics	Immunotherapy company	AMR Action Fund	£6m